接受同步放化疗的肺癌患者的支持治疗建议
欧洲放射肿瘤学会(ESTRO)与欧洲肿瘤内科学会(ESMO)专家组针对适合的III期非小细胞肺癌患者接受同步放化疗期间的支持治疗提出建议,涵盖戒烟、营养、运动、急性食管炎与吞咽困难防治、咳嗽与呼吸困难治疗、皮肤反应处理、疲乏治疗、恶心呕吐预防、心脏疾病防治以及放疗技术优化和化疗调整,并指出知识缺口。
要点
- 同步放化疗是多数适合的III期非小细胞肺癌患者的标准治疗,但毒性可累及所有器官系统并可能致命。
- 支持治疗应覆盖戒烟、营养、运动、急性食管炎/吞咽困难、咳嗽/呼吸困难、皮肤反应、疲乏、恶心呕吐及心脏毒性防治。
- 在免疫治疗时代需优化放疗技术并调整化疗以减少毒性,同时识别知识缺口以改善生活质量和生存。
临床应用与阅片要点
- 对接受同步放化疗的III期非小细胞肺癌患者,应关注戒烟、营养(包括厌食的治疗与预防)及运动(治疗前和治疗期间)。
- 应防治急性食管炎和吞咽困难,治疗咳嗽、呼吸困难、皮肤反应和疲乏,并预防恶心呕吐。
- 应防治心脏疾病和心脏损伤,并在免疫治疗时代优化放疗技术、调整化疗以减少毒性。
局限性
- 原文指出存在知识缺口,未来需要投入研究以改善支持治疗,从而提高III期非小细胞肺癌患者的生活质量和生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Concurrent chemotherapy and radiotherapy (CCRT) followed by durvalumab immune therapy in appropriate patients is considered to be the standard of care in most fit stage III non-small-cell lung cancer (NSCLC) patients. However, CCRT is a toxic treatment that affects all organ systems and may cause acute and permanent side effects, some of which may be lethal. Supportive care is therefore of utmost importance in this clinical setting. A group of experts from the European Society for Therapeutic Radiology and Oncology (ESTRO) and the European Society of Medical Oncology (ESMO) identified the following items of importance for further improvement of supportive care: smoking cessation; nutrition before and during CCRT (including treatment and prevention of anorexia); physical exercise before and during CCRT; prevention and treatment of acute esophagitis and dysphagia; treatment of cough and dyspnea; treatment of skin reactions; treatment of fatigue; prophylaxis of nausea and emesis; prevention, diagnosis, and treatment of cardiac disease and damage; and optimization of radiotherapy techniques and chemotherapy adjustments to reduce toxicity in the era of immune therapy. The resulting recommendations are summarized in this manuscript and knowledge gaps identified, in which future investments are needed to improve supportive care and hence quality of life and survival for our stage III NSCLC patients.
引用
- De Ruysscher D, Faivre-Finn C, Nackaerts K, et al. Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer. Ann Oncol. 2020. PMID: 31912794. doi:10.1016/j.annonc.2019.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。